It could be argued that headache attacks are mediated by the activation of specific isoforms of KATP channels sulfonylurea receptor subunits, and KATP blockers more selective than glibenclamide are needed to further elucidate the role of potassium channels in migraine pathophysiological mechanisms. The gene discussed is KCNA3; the disease is migraine disorder.